SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017421
Filing Date
2022-08-15
Accepted
2022-08-15 17:22:30
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atha-20220630.htm   iXBRL 10-Q 3068089
2 EX-31.1 atha-ex31_1.htm EX-31.1 19333
3 EX-31.2 atha-ex31_2.htm EX-31.2 19193
4 EX-32.1 atha-ex32_1.htm EX-32.1 11456
5 EX-32.2 atha-ex32_2.htm EX-32.2 9839
6 GRAPHIC img104320290_0.jpg GRAPHIC 379875
  Complete submission text file 0000950170-22-017421.txt   10076299

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atha-20220630_lab.xml EX-101.LAB 400667
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atha-20220630_pre.xml EX-101.PRE 282451
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atha-20220630.xsd EX-101.SCH 52400
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atha-20220630_def.xml EX-101.DEF 139044
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atha-20220630_cal.xml EX-101.CAL 41084
66 EXTRACTED XBRL INSTANCE DOCUMENT atha-20220630_htm.xml XML 1760309
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39503 | Film No.: 221166806
SIC: 2836 Biological Products, (No Diagnostic Substances)